Abbott Laboratories Stock NEO Exchange
Stocks
ABT
CA0028221046
Medical Equipment, Supplies & Distribution
| Market Cap | 172B 150B 139B 128B 241B 16,578B 247B 1,659B 653B 8,119B 646B 632B 27,950B | P/E 2026 * |
26.9x | P/E 2027 * | 21.3x |
|---|---|---|---|---|---|
| Enterprise Value | 196B 171B 158B 145B 274B 18,829B 280B 1,885B 741B 9,222B 734B 718B 31,746B | EV / Sales 2026 * |
3.89x | EV / Sales 2027 * | 3.44x |
| Free-Float |
86.73% | Yield 2026 * |
2.62% | Yield 2027 * | 2.75% |
Last Transcript: Abbott Laboratories
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 172B | |
| -0.50% | -0.81% | -7.08% | -4.06% | 107B | |
| -0.21% | +1.25% | +4.37% | +59.90% | 59.92B | |
| -1.47% | +3.81% | -12.81% | -38.54% | 44.07B | |
| -2.97% | -2.70% | - | - | 34.76B | |
| -2.16% | +1.81% | -9.25% | -44.47% | 30.09B | |
| -0.57% | +1.67% | +62.28% | -6.26% | 25.61B | |
| -0.91% | +1.31% | -3.73% | -18.94% | 20.86B | |
| -1.69% | +0.61% | -3.24% | -4.83% | 21.55B | |
| +2.74% | +1.80% | -6.96% | +4.13% | 20.04B | |
| Average | -0.77% | +2.65% | +2.95% | -6.63% | 40.43B | |
| Weighted average by Cap. | -0.59% | +2.50% | -0.09% | -1.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.32B 43.97B 40.58B 37.4B 70.5B 4,846B 72.06B 485B 191B 2,373B 189B 185B 8,170B | 54.63B 47.74B 44.06B 40.61B 76.54B 5,261B 78.24B 527B 207B 2,577B 205B 201B 8,871B |
| Net income | 6.62B 5.79B 5.34B 4.92B 9.28B 638B 9.48B 63.82B 25.1B 312B 24.87B 24.32B 1,075B | 8.16B 7.13B 6.58B 6.07B 11.43B 786B 11.69B 78.66B 30.94B 385B 30.65B 29.98B 1,325B |
| Net Debt | 23.38B 20.43B 18.85B 17.38B 32.76B 2,252B 33.48B 225B 88.64B 1,103B 87.81B 85.88B 3,796B | 15.74B 13.76B 12.7B 11.7B 22.06B 1,516B 22.55B 152B 59.69B 743B 59.13B 57.83B 2,556B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
